Literature DB >> 8960030

Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1.

M E Bailey1, R W Brown, D R Mody, P Cagle, I Ramzy.   

Abstract

OBJECTIVE: To evaluate the efficacy of Ber-EP4 in distinguishing epithelial cells from mesothelial cells in routine cytologic preparations. STUDY
DESIGN: Paraffin-embedded cell blocks of serous effusions from 32 patients (11 metastatic adenocarcinomas, 16 reactive mesothelial proliferations and 5 malignant mesotheliomas) were immunostained with Ber-EP4. For comparison, cell block preparations of adenocarcinomas and mesotheliomas were also immunostained with the most commonly applied markers of adenocarcinoma: carcinoembryonic antigen (CEA), B72.3 and Leu-M1. In addition, cytocentrifuge preparations of 14 reactive effusions and 2 metastatic adenocarcinomas were stained prospectively with Ber-EP4.
RESULTS: All adenocarcinomas showed intense membrane staining, while all mesothelial proliferations, both benign and malignant, were negative. The Ber-EP4-positive immunostaining was remarkably clean, with very minimal nonspecific staining. CEA stained 11/11 adenocarcinomas, B72.3 stained 10/11, and Leu-M1 stained 8/11; mesotheliomas were negative with all three antibodies.
CONCLUSION: Ber-EP4 is at least as useful as CEA, B72.3 and Leu-M1 in the diagnosis of serous effusions. It has the advantage of high sensitivity and ease of interpretation because of the high percentage of tumor cells stained, characteristic membranous staining and lack of cross-reaction with background inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8960030     DOI: 10.1159/000333982

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  5 in total

1.  Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Authors:  C Milsmann; L Füzesi; E Heinmöller; P Krause; C Werner; H Becker; O Horstmann
Journal:  Langenbecks Arch Surg       Date:  2007-09-18       Impact factor: 3.445

2.  Utility of a limited panel of calretinin and Ber-EP4 immunocytochemistry on cytospin preparation of serous effusions: A cost-effective measure in resource-limited settings.

Authors:  Raman Arora; Shipra Agarwal; Sandeep R Mathur; Kusum Verma; Venkateswaran K Iyer; Manju Aron
Journal:  Cytojournal       Date:  2011-07-28       Impact factor: 2.091

3.  Modified Liquid-Based Cytology Technique for Immunocytochemistry in Effusion Specimen.

Authors:  Natcha Patarapadungkit; Porntip Jangsiriwitayakorn; Surachat Chaiwiriyakul; Phannatorn Sirivech; Ratchaneekorn Thongbor; Em-Orn Phanomsri; Luxkana Nititarakul
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

Review 4.  Serous fluid: Reactive conditions.

Authors:  Nirag Jhala; Darshana Jhala; Vinod B Shidham
Journal:  Cytojournal       Date:  2022-03-19       Impact factor: 2.345

5.  Diagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in serous effusions: a meta-analysis.

Authors:  Bo Wang; Diandian Li; Xuemei Ou; Qun Yi; Yulin Feng
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.